Microbiome Research Reports

Microbiome Research Reports is a quarterly gold open access journal released online in July 2021 by OAE Publishing, covering the structure, function and host interactions of microbiomes in humans and animals, with a 2025 Journal Impact Factor of 5.2.《微生物组研究报告》（Microbiome Research Reports）是（OAE Publishing）于 2021 年 7 月上线、按季出版的金色开放获取期刊，研究人与动物微生物组的结构、功能及其与宿主的相互作用，2025 年期刊影响因子为 5.2。

Scope

• The structure, activities and communal behaviour of microbial communities, including community genetics and evolutionary processes.微生物群落的结构、活动与群体行为，包括群落遗传学与演化过程。
• Microbe-microbe interactions and microbe-host communication across the body compartments of humans and other animals.人与其他动物各身体部位中微生物之间的相互作用以及微生物与宿主的交流。
• Viromes and phageomes, fungal communities or mycobiomes, and the exploration of microbial dark matter.病毒组与噬菌体组、真菌群落即真菌组，以及对微生物暗物质的探索。
• Culturomics, gnotobiotic studies, and the design of minimal consortia and synthetic communities for functional host-microbe work.培养组学、悉生生物研究，以及用于宿主—微生物功能研究的最小菌群与合成群落构建。
• Genomics, metatranscriptomics, metabolomics and proteomics applied to microbiomes, together with new pipelines and modelling approaches.面向微生物组的基因组学、宏转录组学、代谢组学与蛋白质组学，以及新的分析流程与建模方法。
• Probiotics, prebiotics, synbiotics and postbiotics, dietary components, microbial metabolites and microbiota modulation in gastrointestinal and metabolic disorders.益生菌、益生元、合生元与后生元，膳食成分、微生物代谢物，以及胃肠与代谢疾病中的菌群调控。
• Microbiome-based therapies, novel treatments and clinical trials, with molecular mechanisms of health and disease especially welcome.基于微生物组的疗法、新型治疗与临床试验，尤其欢迎阐明健康与疾病分子机制的研究。
• Accepted formats include original research, short reports, reviews and commentaries, and the journal runs special topics and topical collections.接受体裁包括原创研究、短报告、综述与评论，并组织专题与主题合集。

History

• The journal was released online on 26 July 2021 with Marco Ventura of the University of Parma as founding editor-in-chief.本刊于 2021 年 7 月 26 日上线，创刊主编为帕尔马大学的（Marco Ventura）。
• The inaugural issue appeared in March 2022, and the journal joined the Committee on Publication Ethics on 11 November 2022.首期于 2022 年 3 月正式出版，2022 年 11 月 11 日加入出版伦理委员会（COPE）。
• PubMed Central and Scopus indexing followed in December 2023, and the title was accepted for the Emerging Sources Citation Index in August 2024.2023 年 12 月被（PubMed Central）与（Scopus）收录，2024 年 8 月获准进入新兴来源引文索引（ESCI）。
• Its first Journal Impact Factor was 3.8 in the 2024 release, ranking 58 of 163 in microbiology, and the 2025 figure rose to 5.2 at rank 42 of 167.首个期刊影响因子为 2024 年发布的 3.8，在微生物学类别排名 58/163，2025 年升至 5.2，排名 42/167。
• CiteScore climbed from 3.3 for 2024 to 6.6 for 2025, and the journal appears quarterly, with volume 5 covering 2026.（CiteScore）由 2024 年的 3.3 升至 2025 年的 6.6，期刊按季出版，2026 年为第 5 卷。
• Publication is gold open access under CC BY 4.0 with an article processing charge of 2600 US dollars and no charges for colour or length.出版为金色开放获取，采用（CC BY 4.0）许可，文章处理费 2600 美元，不另收彩图费或超长费。

Editors

• Marco Ventura of the University of Parma in Italy is editor-in-chief, and Douwe van Sinderen of University College Cork in Ireland is co-editor-in-chief.主编为意大利帕尔马大学的（Marco Ventura），共同主编为爱尔兰科克大学的（Douwe van Sinderen）。
• About 43 editors sit on the board, among them Liping Zhao, Emma Allen-Vercoe, Rodolphe Barrangou, Sarah Lebeer, Dirk Haller, Erwin Zoetendal and Karen Scott.编委会约 43 人，其中包括（Liping Zhao）、（Emma Allen-Vercoe）、（Rodolphe Barrangou）、（Sarah Lebeer）、（Dirk Haller）、（Erwin Zoetendal）与（Karen Scott）。
• Members are drawn from Italy, Ireland, the United States, Spain, the United Kingdom and the Netherlands, and ten of them appeared on the 2023 Highly Cited Researchers list.编委来自意大利、爱尔兰、美国、西班牙、英国与荷兰，其中 10 人入选 2023 年高被引学者名单。
• A junior editorial board gives early-career researchers a role in handling and reviewing manuscripts.期刊另设青年编委会，让青年研究者参与稿件处理与评审。
• Review is single blind, and the journal reports a median time to first editorial decision of seven days.评审采用单盲方式，期刊公布的首轮编辑决定中位时间为 7 天。